HIRUDOID

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Finland, Hong Kong SAR China, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, UK.

Active ingredients

The drug HIRUDOID contains one active pharmaceutical ingredient (API):

1	Heparinoid
	Heparinoid is recognised as having: a weak inhibitory effect on PGE2 synthesis and an indirect effect on LTB4 production (based on in vitro studies), anti-coagulant activity (as a heparinoid), thrombolytic activity (through potentiation of urokinase activity), anti-exudatory activity (through inhibition of hyaluronidase).

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HIRUDOID Cream	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C05BA01	Organo-heparinoid	C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BA Heparins or heparinoids for topical use
Discover more medicines within C05BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	530413040008803, 530413040008903, 530413040009003, 530413040009103, 530413040009203, 530417040013903, 530417040014003
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	363571212, 369521213, 435-MEE-0914
EE	Ravimiamet	1029237, 1029248, 1071762, 1071773
FI	Lääkealan turvallisuus- ja kehittämiskeskus	098347, 098358, 098370, 098381, 470831, 470930
GB	Medicines & Healthcare Products Regulatory Agency	31572, 31586
HK	Department of Health Drug Office	07059, 39212, 57432
JP	医薬品医療機器総合機構	2649950M1143, 3339950M1137, 3339950N1035, 3339950R1177
LT	Valstybinė vaistų kontrolės tarnyba	1009113, 1009114, 1009115, 1010190
NL	Z-Index G-Standaard	12124427, 12124435
NL	Z-Index G-Standaard, PRK	1112
NZ	Medicines and Medical Devices Safety Authority	439
PL	Rejestru Produktów Leczniczych	100029058, 100249328, 100293134, 100304903, 100306523, 100348510, 100348585, 100359206, 100385439, 100400475, 100426776
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W01841001, W01842001
SG	Health Sciences Authority	04236P, 04421P, 14339P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699527341523, 8699527351546